See more : Xali Gold Corp. (CGDXF) Income Statement Analysis – Financial Results
Complete financial analysis of HeartBeam, Inc. (BEAT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HeartBeam, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- Dropsuite Limited (DSE.AX) Income Statement Analysis – Financial Results
- Sarcos Technology and Robotics Corporation (STRCW) Income Statement Analysis – Financial Results
- Al-Jouf Agricultural Development Co. (6070.SR) Income Statement Analysis – Financial Results
- Hybrid Financial Services Limited (HYBRIDFIN.BO) Income Statement Analysis – Financial Results
- SeaStar Medical Holding Corporation (ICU) Income Statement Analysis – Financial Results
HeartBeam, Inc. (BEAT)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.heartbeam.com
About HeartBeam, Inc.
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 399.47M | 286.78M | 208.33M | 178.51M | 166.58M | 129.50M | 111.49M | 119.02M | 119.92M | 140.62M | 120.45M | 72.99M | 33.92M | 30.94M | 22.23M | 7.92M |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 148.99M | 114.41M | 78.88M | 71.96M | 73.11M | 50.43M | 45.59M | 49.08M | 47.49M | 48.69M | 39.91M | 25.53M | 12.70M | 0.00 | 16.97M | 5.66M |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 250.49M | 172.37M | 129.45M | 106.56M | 93.46M | 79.07M | 65.90M | 69.95M | 72.43M | 91.93M | 80.54M | 47.47M | 21.22M | 30.94M | 5.26M | 2.26M |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 62.70% | 60.11% | 62.14% | 59.69% | 56.11% | 61.06% | 59.11% | 58.77% | 60.40% | 65.38% | 66.86% | 65.03% | 62.56% | 100.00% | 23.66% | 28.51% |
| Research & Development | 6.80M | 5.68M | 255.00K | 133.00K | 41.00K | 11.21M | 11.10M | 8.36M | 7.11M | 7.40M | 7.34M | 4.66M | 5.70M | 4.90M | 5.81M | 4.00M | 3.78M | 3.63M | 0.00 | 2.41M | 4.44M |
| General & Administrative | 8.52M | 7.35M | 2.03M | 655.00K | 0.00 | 112.43M | 88.60M | 56.60M | 47.93M | 45.80M | 37.06M | 33.42M | 35.01M | 34.66M | 39.15M | 41.92M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 42.85M | 35.32M | 28.64M | 27.94M | 28.81M | 26.28M | 25.60M | 27.82M | 29.34M | 34.66M | 21.11M | 0.00 | 0.00 | 0.00 | 7.70M | 3.53M |
| SG&A | 8.52M | 7.35M | 2.03M | 655.00K | 253.00K | 155.28M | 123.92M | 85.23M | 75.87M | 74.61M | 63.34M | 59.03M | 62.83M | 64.00M | 73.81M | 63.03M | 0.00 | 0.00 | 0.00 | 7.70M | 3.53M |
| Other Expenses | 0.00 | 3.00K | 22.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.08M | 18.58M | 19.98M | -1.06M | 43.44M | 22.08M | 0.00 | 15.25M | 7.02M |
| Operating Expenses | 15.31M | 13.03M | 2.29M | 788.00K | 294.00K | 166.48M | 135.02M | 93.59M | 82.98M | 82.00M | 70.67M | 63.69M | 80.61M | 87.47M | 99.60M | 65.97M | 47.22M | 25.71M | 0.00 | 25.36M | 14.99M |
| Cost & Expenses | 15.31M | 13.03M | 2.29M | 788.00K | 294.00K | 315.47M | 249.43M | 172.47M | 154.94M | 155.12M | 121.11M | 109.28M | 129.69M | 134.96M | 148.29M | 105.88M | 72.75M | 38.41M | 0.00 | 42.33M | 20.65M |
| Interest Income | 675.00K | 66.00K | 2.17K | 280.00 | 242.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 66.00K | 2.17M | 280.00K | 242.00K | 9.43M | 4.90M | 0.00 | 0.00 | 0.00 | 0.00 | 299.00K | 0.00 | 3.00K | 12.00K | 170.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 15.31M | 13.03M | 2.29M | 788.00K | 294.00K | 40.17M | 28.56M | 14.27M | 12.49M | 12.55M | 12.32M | 9.38M | 12.13M | 12.07M | 10.94M | 8.69M | 4.55M | 2.66M | -42.40M | -848.00K | 46.00K |
| EBITDA | 675.00K | -13.03M | 0.00 | -788.00K | -294.00K | 92.05M | 24.25M | 30.04M | 20.38M | 444.00K | 5.21M | -3.43M | -49.05M | -7.52M | -9.52M | 19.55M | 4.19M | -4.99M | -11.46M | -20.95M | -12.68M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 23.04% | 8.46% | 14.42% | 11.42% | 0.27% | 4.03% | -3.08% | -41.21% | -6.27% | -6.77% | 16.23% | 5.74% | -14.71% | -37.05% | -94.22% | -160.04% |
| Operating Income | -15.31M | -13.03M | -2.29M | -788.00K | -294.00K | 84.00M | 37.35M | 35.86M | 23.58M | 11.46M | 8.40M | 2.21M | -10.66M | -15.04M | -7.67M | 14.57M | 241.61K | -4.49M | 30.94M | -20.10M | -12.73M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 21.03% | 13.02% | 17.21% | 13.21% | 6.88% | 6.48% | 1.98% | -8.96% | -12.54% | -5.45% | 12.10% | 0.33% | -13.23% | 100.00% | -90.41% | -160.62% |
| Total Other Income/Expenses | 675.00K | 69.00K | -2.14M | -280.00K | -242.00K | -42.50M | -47.75M | -20.09M | -15.68M | -23.57M | -15.50M | -15.32M | -50.51M | -4.56M | -12.80M | -3.88M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -14.64M | -12.96M | -4.43M | -1.07M | -536.00K | 41.50M | -10.40M | 15.77M | 7.90M | -12.11M | -7.10M | -13.11M | -61.18M | -19.60M | -20.47M | 10.69M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 10.39% | -3.63% | 7.57% | 4.42% | -7.27% | -5.49% | -11.76% | -51.40% | -16.34% | -14.56% | 8.87% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -135.00K | 2.17M | 280.00K | 242.00K | -370.00K | 6.75M | -37.67M | 468.00K | -2.31M | 215.00K | -905.00K | 244.00K | 262.00K | 5.00K | 1.48M | 0.00 | 0.00 | 42.40M | 848.00K | -46.00K |
| Net Income | -14.64M | -12.83M | -6.59M | -1.35M | -778.00K | 42.82M | -15.96M | 53.44M | 7.43M | -9.79M | -7.32M | -12.20M | -61.42M | -19.86M | -20.48M | 9.21M | -358.07K | -7.64M | -11.46M | -20.95M | -12.68M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 10.72% | -5.56% | 25.65% | 4.16% | -5.88% | -5.65% | -10.94% | -51.61% | -16.56% | -14.56% | 7.64% | -0.49% | -22.54% | -37.05% | -94.22% | -160.04% |
| EPS | -0.72 | -1.57 | -0.84 | -0.17 | -0.10 | 1.20 | -0.53 | 1.91 | 0.27 | -0.37 | -0.29 | -0.49 | -2.51 | -0.82 | -0.86 | 0.50 | -0.12 | -2.63 | -4.04 | -7.33 | -5.23 |
| EPS Diluted | -0.72 | -1.57 | -0.84 | -0.17 | -0.10 | 1.20 | -0.53 | 1.75 | 0.26 | -0.37 | -0.29 | -0.49 | -2.51 | -0.82 | -0.86 | 0.41 | -0.12 | -2.63 | -4.04 | -7.33 | -5.23 |
| Weighted Avg Shares Out | 20.33M | 8.17M | 7.81M | 8.17M | 8.17M | 35.78M | 30.39M | 27.92M | 27.12M | 26.45M | 25.54M | 24.93M | 24.43M | 24.11M | 23.77M | 18.35M | 2.91M | 2.91M | 2.84M | 2.86M | 2.42M |
| Weighted Avg Shares Out (Dil) | 20.33M | 8.17M | 7.81M | 8.17M | 8.17M | 35.78M | 30.39M | 30.49M | 29.09M | 26.45M | 25.54M | 24.93M | 24.43M | 24.11M | 23.77M | 22.66M | 2.91M | 2.91M | 2.84M | 2.86M | 2.42M |
BioTelemetry soars 18% after Philips announces acquisition of cardiac-diagnostics company
BioTelemetry gained as much as 18% on Friday after news that the cardiac-diagnostics firm will be acquired by Dutch company Royal Philips for $2.8 billion. BioTelemetry is a Pennsylvania-based medical company that makes equipment that remotely diagnoses and monitors cardiac...
BioTelemetry Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of BioTelemetry, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – BEAT
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of BioTelemetry, Inc. (NASDAQ: BEAT) to Royal Philips for $72.00 per share in cash is fair to BioTelemetry shareholders. Halper Sadeh encourages BioTelemetry shareholders...
(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price?
SAN DIEGO, Dec. 18, 2020 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of BioTelemetry, Inc. (NASDAQ: BEAT) breached their fiduciary duties in connection with the proposed sale of the...
Philips to Acquire BioTelemetry
MALVERN, Pa., Dec. 18, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT) , the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced that they...
BioTelemetry Has Sequential Upside Via Double-Digit Growth Into 2021
BioTelemetry has had a better than expected third quarter, leveraging new patient uptake plus clinician accounts in their healthcare and continuous care segments. Management have secured better lending terms on their revolving facility, and cash runaway is well over 2...
BioTelemetry's (BEAT) CEO Joseph Capper on Q3 2020 Results - Earnings Call Transcript
BioTelemetry's (BEAT) CEO Joseph Capper on Q3 2020 Results - Earnings Call Transcript
BioTelemetry, Inc. Reports Third Quarter 2020 Financial Results
Posts Record Quarterly Revenue Amidst Rapid Recovery Posts Record Quarterly Revenue Amidst Rapid Recovery
Global Telehealth Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2020-2024
Telehealth market will register an incremental spend of about $11 billion, growing at a CAGR of 26.19% during the five-year forecast period.
Global Mobile Health App Market 2020: Industry Demand and Forecast to 2025 By Company Overview, Share, Size, Expansions, Agreements, New Product Launches and Growth Analysis
Oct 07, 2020 (The Expresswire) -- Global "Mobile Health App Market" 2020: - Mobile Health App Market report intends to offer inside and out data about Mobile...
Source: https://incomestatements.info
Category: Stock Reports